Redhill Biopharma
RDHL
#11160
Rank
S$3.22 M
Marketcap
S$0.36
Share price
-13.08%
Change (1 day)
-73.34%
Change (1 year)

EPS for Redhill Biopharma (RDHL)

EPS in 2023 (TTM): S-$1,016

According to Redhill Biopharma's latest financial reports the company's current EPS (TTM) is S-$903.00. In 2017 the company made an earnings per share (EPS) of S-$3,225 a decrease over its 2016 EPS that were of S-$2,838.

EPS history for Redhill Biopharma from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)S-$1,016
2017S-$3,22513.64%
2016S-$2,8389.12%
2015S-$2,60168.01%
2014S-$1,548-25.93%
2013S-$2,090

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
S$2.55-100.28%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
S$1.28-100.14%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$3.71-100.41%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
S$0.58-100.06%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
S$1.57-100.17%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel